Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Editor In Chief

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD, has disclosed that he has received consulting fees and fees for non-CME/CE services from AbbVie, Gilead Sciences, and Merck. Dr. Zeuzem has disclosed in previous editions that he had served as a consultant or on advisory boards for Abbott, AbbVie, Achillion, Anadys, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Idenix, iTherX, Janssen, Merck, Novartis, Pfizer, Pharmasset, Presidio, Roche, Santaris, Tibotec/Janssen, and Vertex and had served on speaker bureaus for AbbVie, Bristol-Myers Squibb, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and Roche.
Author

Mark S. Sulkowski, MD

Professor of Medicine
Medical Director,
Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology/Hepatology
Johns Hopkins University School of Medicine
Baltimore, Maryland

Mark S. Sulkowski, MD, has disclosed that he has received consulting fees from AbbVie, Achillion, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Merck, and has received funds for research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Merck. In previous editions, Dr. Sulkowski disclosed that he had served on an advisory board for Boehringer Ingelheim, Pfizer, Roche, and Vertex, and had received funds for research support from Boehringer Ingelheim and Roche.

Staff

Edward King, MA

Executive Vice President

Edward King, MA, has no real or apparent conflicts of interest to report.

Jennifer M. Blanchette, PhD

Managing Editor

Jennifer M. Blanchette, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Megan Cartwright, PhD

Clinical Editor

Megan Cartwright, PhD, has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Clinical Editor

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.
Additional Disclosure Information

The following faculty and staff have previously contributed to the content of this module and disclosed the following potential conflicts of interest:

Nezam H. Afdhal, MD, FRCPI, disclosed that he had served as a consultant or on advisory boards for AbbVie, Achillion, Boehringer Ingelheim, Biogen, Biolex, Echosens, FibroGen, Gilead Sciences, GlaxoSmithKline, Idera, Janssen, Kadmon, Ligand, Medgenics, Merck, Novartis, Spring Bank, and Vertex; had received funds for research support from Abbott, AbbVie, Bristol-Myers Squibb, Echosens, Gilead Sciences, GlaxoSmithKline, Merck, Novartis, Quest, and Vertex; and had held stock options for Medgenics and Spring Bank at the time he contributed to this module.

Michael R. Charlton, MD; Taryn O’Loughlin Gross, PhD; Kiran Mir-Hudgeons, PhD; Jennifer L. Shoemaker, PhD; Melinda B. Tanzola, PhD; Steven McGuire; Katherine L. DeYoung, PhD; Anna Poppa; Elaine P. Seekin; and Heather Stieglitz, PhD, had no real or apparent conflicts of interest to report at the time they contributed to this module.

Norah Terrault, MD, MPH, had disclosed that she had served as a consultant for Biotest, Bristol-Myers Squibb, Gilead Sciences, Merck, Pfizer, Roche/Genentech, and Siemens and had received funds for research support from Bristol-Myers Squibb, Eisai, Gilead Sciences, Merck, Novartis, and Roche/Genentech at the time she contributed to this module.

Heiner Wedermeyer, MD, had disclosed that he had received consulting fees from Achillion, AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Janssen Therapeutics, Merck/MSD, Novartis, and Roche at the time he contributed to this module.

Disclaimer

The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Contact Information

If you have technical queries about using this site, please contact: techhelp@clinicaloptions.com.

If you have credit related queries or a complaint, please contact: skelley@clinicaloptions.com.

inPractice Hepatology current certification period
Release Date: March 2, 2020
Expiration Date: March 1, 2021

Target Audience

This program is intended for physicians and other healthcare professionals involved in the medical management of patients with or at risk of viral hepatitis.

Goal:

The goal of this activity is to improve learners’ knowledge and competence regarding the clinical management of patients with viral hepatitis.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

Commercial Support

This program is supported by educational grants from AbbVie.


inPractice HIV current certification period
Release Date: September 26, 2019
Expiration Date: September 25, 2020

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the management of patients with HIV.

Goal:

The goal of this activity is to provide a comprehensive clinical reference resource on the prevention, diagnosis, and treatment of HIV disease.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

Commercial Support:

This program is supported by educational grants from Gilead Sciences and ViiV Healthcare.


For inPractice Hepatology and HIV

Physician Continuing Medical Education (for Point of Care CME activities)
CCO

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


CCO designates this internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Credit (Point of Care CME)

inPractice offers physicians AMA PRA Category 1 CreditTM for participation in this individual Internet point-of-care activity. Physicians may claim 0.5 credits per search. To claim point-of-care (PoC) CME credit through inPractice, eligible physicians must complete the following steps:

  1. Register online at http://www.inpractice.com
  2. Execute a search or submit a clinical question
  3. Review the applicable clinical sources
  4. Click the "Claim CME Credit" button at the top right corner of the content you have viewed
  5. Complete the simple evaluation questions addressing clinical application of learnings from the sources you have consulted

After submitting the evaluation, you will be presented with your online CME certificate as a pdf file. Records of all CME activities completed can be found on the "My CME" page.